Stereotactic Body Radiotherapy for Spine Tumors

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Spinal MetastasesVertebral MetastasesBenign Spinal TumorsChordomaMeningiomaSchwannomaNeurofibromaParagangliomasArteriovenous Malformations
Interventions
RADIATION

SBRT for Benign Extradural Spine Tumors

14-25 Gy / 1 fraction OR 21-27 Gy / 3 fractions (7-9 Gy per fraction) OR 25-30 Gy / 5 fractions (5-6 Gy per fraction)

RADIATION

SBRT for Vertebral/Paraspinal Metastases

12-16 Gy / 1 fraction OR 21-27 Gy / 3 fractions (7-9 Gy per fraction) OR 25-30 Gy / 5 fractions (5-6 Gy per fraction)

Trial Locations (1)

63141

Mercy Medical Center, St. Louis, St Louis

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mercy Research

OTHER

NCT01347307 - Stereotactic Body Radiotherapy for Spine Tumors | Biotech Hunter | Biotech Hunter